Serapin, Gliedyl Queen G.
HRN: 01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2022
CEFUROXIME 750MG (VIAL)
04/07/2022
04/13/2022
IV
750MG
Q8H
DENGUE FEVER; PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes